Intracranial Aneurysm Market Size

Intracranial Aneurysm Market size is expected to rise by USD 2.9 billion between 2025 and 2037, driven by a CAGR of more than 9.1%. The projected industry size of intracranial aneurysm in 2025 is USD 1.49 billion.

The primary growth driver is the rising prevalence of neurological disorders and intracranial aneurysms globally. According to the Institute for Health Metrics and Evaluation (IHME), neurological disorders were the top contributor to the global disease burden in 2021, affecting 43% of the world’s population.

The growing prevalence of conditions such as hypertension, smoking, excessive alcohol consumption, and obesity significantly contributes to the risk of intracranial aneurysms. Aging populations globally also face higher risks of developing aneurysms, boosting demand for diagnostic and treatment solutions. The development of advanced imaging techniques, such as CT angiography, MRI, and digital subtraction angiography (DSA), has improved early detection and diagnosis of intracranial aneurysms. Enhanced accuracy in diagnosing asymptomatic aneurysms drives treatment adoption rates.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of intracranial aneurysm is evaluated at USD 1.49 billion.

The intracranial aneurysm market size was valued at USD 1.38 billion in 2024 and is set to exceed USD 4.28 billion by 2037, expanding at over 9.1% CAGR during the forecast period i.e., between 2025-2037.

North America industry is likely to account for largest revenue share of 29.7% by 2037, attributed to combination of technological advancements, increasing prevalence of risk factors, and robust healthcare infrastructure.

The major players in the market include Medtronic plc, Stryker Corporation, MicroPort Scientific Corporation, Johnson & Johnson Services, Inc., MicroVention Inc., B. Braun Melsungen AG, Integra LifeSciences, and others.

Intracranial Aneurysm Market Size